A Clinical Study to Evaluate the Safety and Efficacy of ESO-T01 in Treating Relapsed/Refractory Multiple Myeloma.
Clinical trial NCT06691685 · SUSPENDED
Trial details
- NCT number
- NCT06691685
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- SUSPENDED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-18
- Primary completion
- 2027-11-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.